Richter Biologics is a Hamburg-based biopharmaceutical CDMO with two cGMP-compliant manufacturing facilities in Germany. The company specializes in microbial products derived from bacteria and yeasts, offering high-quality services from cell, process, and analytical development through GMP-compliant commercial manufacturing. Over the past 30 years, Richter Biologics has developed and manufactured a variety of products, including recombinant proteins and peptides, plasmid DNA, and bacterial vaccines.
